Search Within

Nursing

  1. "Annals of Oncology"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (13)
Groups
  1. Department of Medicine (24)
  2. Solid Tumor Oncology Division (20)
  3. Advanced Practice Providers (9)
  4. Gastrointestinal Oncology Service (8)
  5. Hematologic Malignancies, Division of (8)
  6. Center for Hematologic Malignancies (6)

More Groups

People
  1. Eileen O'Reilly (4)
  2. Carol Portlock (3)
  3. Craig Moskowitz (3)
  4. Mark Kris (3)
  5. Mrinal Gounder (3)
  6. Alexander Drilon (2)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2021 (1)
  4. 2020 (1)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Annals of Oncology (26)
Publishers
  1. Oxford University Press (26)

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • PD-1 blockade as curative intent therapy in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Stadler, Z.; Yaeger, R.; Smith, J. J.; Saltz, L.; Widmar, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Consensus views on research priorities for cancer survivorship in older adulthood: A Delphi study
    Meeting Abstract

    Drury, A.; O'Brien, A.; O'Connell, L.; Cosgrave, S.; Hannan, M.; Smyth, C.; Fessele, K.; Sheehan, S.; Harkin, M.; Rogers, L.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Simulation training for compassionate extubation in the pediatric intensive care unit
    Meeting Abstract

    Fernandez, N.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Response of thrombopoietin receptor agonists in MDM2 inhibitor induced thrombocytopenia
    Meeting Abstract

    DeMatteo, R.; Sgroe, E.; Merrill, M. B.; Gounder, M.; Liu, D.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib in patients with MET-altered lung cancers
    Meeting Abstract

    Harada, G.; Santini, F. C.; Repetti, R. W.; Chang, J.; Yang, S. R.; Lin, Y. T.; Moses, K. A.; Falcon, C.; Wilhelm, C. J.; Goldstein, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Zhao, J. L.; Antonarakis, S.; Cheng, H.; George, D. J.; Aggarwal, R. R.; Abida, W.; Decker, B.; Smart-Curley, T.; Schonhoft, J.; Anderson, A.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Characterization of on-target adverse events caused by TRK inhibitor therapy
    Journal Article

    Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
    Meeting Abstract

    Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Qin, S.; Ryoo, B. Y.; Lu, S. N.; Yen, C. J.; Feng, Y. H.; Lim, H. Y.; Izzo, F.; Colombo, M.; Sarker, D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save